sodium glutamate has been researched along with Diabetes Mellitus in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Błońska-Fajfrowska, B; Hartman-Petrycka, M; Knefel, G; Lebiedowska, A; Nowak, M | 1 |
Chen, W; Li, S; Meng, A; Wang, L; Xie, X; Zhang, N; Zhou, X | 1 |
Baba, H; Fujimoto, M; Hayashi, S; Hokao, R; Imura, J; Miwa, S; Nakajima, T; Nishida, T; Nomoto, K; Oda, E; Sutoh, M; Taira, S; Tsuneyama, K | 1 |
Aburada, M; Fujimoto, M; Hokao, R; Iizuka, S; Miyamoto, K; Nagata, M; Nakamura, S; Sasaki, Y; Shimada, T; Suzuki, W; Tsuneyama, K | 1 |
Aburada, M; Hokao, R; Iizuka, S; Makihara, H; Sasaki, Y; Shimada, T; Suzuki, W; Teraoka, R; Tsuneyama, K | 1 |
Cameron, DP; Poon, TK; Smith, GC | 1 |
6 other study(ies) available for sodium glutamate and Diabetes Mellitus
Article | Year |
---|---|
Taste perception and food preferences in patients with diabetic foot ulcers before and after hyperbaric oxygen therapy.
Topics: Citric Acid; Diabetes Mellitus; Diabetic Foot; Food Preferences; Humans; Hyperbaric Oxygenation; Quinine; Sodium Chloride; Sodium Glutamate; Taste; Taste Perception | 2022 |
C333H ameliorated insulin resistance through selectively modulating peroxisome proliferator-activated receptor γ in brown adipose tissue of db/db mice.
Topics: Adipose Tissue, Brown; Adipose Tissue, White; Animals; Blood Glucose; Cell Line, Tumor; Diabetes Mellitus; Furans; Gene Expression Regulation; Humans; Insulin; Insulin Resistance; Leptin; Male; Mice; Obesity; Organ Size; Oxazoles; PPAR gamma; Rats; Rats, Wistar; Sodium Glutamate | 2013 |
Neonatal monosodium glutamate treatment causes obesity, diabetes, and macrovesicular steatohepatitis with liver nodules in DIAR mice.
Topics: Animals; Blood Glucose; Body Mass Index; Cholesterol; Diabetes Mellitus; Flavoring Agents; Humans; Liver; Male; Metabolic Syndrome; Mice, Inbred Strains; Non-alcoholic Fatty Liver Disease; Obesity; Sodium Glutamate; Triglycerides | 2014 |
Dose dependent development of diabetes mellitus and non-alcoholic steatohepatitis in monosodium glutamate-induced obese mice.
Topics: Animals; Animals, Newborn; Body Mass Index; Body Weight; Diabetes Mellitus; Dose-Response Relationship, Drug; Female; Food Additives; Glucose; Liver; Liver Cirrhosis; Male; Mice; Mice, Inbred ICR; Mice, Obese; Sodium Glutamate | 2009 |
Effects of bezafibrate in nonalcoholic steatohepatitis model mice with monosodium glutamate-induced metabolic syndrome.
Topics: Adipose Tissue; Animals; Bezafibrate; Diabetes Mellitus; Disease Models, Animal; Eating; Fatty Liver; Gene Expression Regulation; Glucose Tolerance Test; Glycosuria; Hypolipidemic Agents; Lipid Metabolism; Liver; Male; Metabolic Syndrome; Mice; Non-alcoholic Fatty Liver Disease; Obesity; Organ Size; RNA, Messenger; Sodium Glutamate | 2011 |
Effects of monosodium glutamate administration in the neonatal period on the diabetic syndrome in KK mice.
Topics: Administration, Oral; Animals; Animals, Newborn; Blood Glucose; Diabetes Mellitus; Fasting; Glucose; Glutamates; Hypothalamus; Injections, Intraperitoneal; Insulin; Mice; Mice, Obese; Sodium Glutamate | 1976 |